Insulet: Number of Employees 2010-2024 | PODD
Interactive chart of Insulet (PODD) annual worldwide employee count from 2010 to 2024.
- Insulet total number of employees in 2023 was 3,000, a 15.38% increase from 2022.
- Insulet total number of employees in 2022 was 2,600, a 13.04% increase from 2021.
- Insulet total number of employees in 2021 was 2,300, a 21.05% increase from 2020.
- Insulet total number of employees in 2020 was 1,900, a 40.74% increase from 2019.
| Insulet Annual Employee Count | |
|---|---|
| 2023 | 3,000 |
| 2022 | 2,600 |
| 2021 | 2,300 |
| 2020 | 1,900 |
| 2019 | 1,350 |
| 2018 | 1,169 |
| 2017 | 857 |
| 2016 | 640 |
| 2015 | 647 |
| 2014 | 519 |
| 2013 | 478 |
| 2012 | 538 |
| 2011 | 576 |
| 2010 | 310 |
| 2009 | 276 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $14.411B | $1.697B |
| Insulet Corporation is a leading developer, manufacturer and marketer of the Omnipod Insulin Management System. The system is equipped with a self-adhesive, small and lightweight disposable tubeless Omnipod device along with the wireless and handheld Personal Diabetes Manager (PDM). The Omnipod System is an innovative, discreet and easy-to-use continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System consists of Omnipod Insulin Management System ('Omnipod') and the Omnipod DASH Insulin Management System - Insulet's next generation digital mobile Omnipod platform. Insulet has tied up with pharmaceutical and biotechnological companies using customized form of the Omnipod System to deliver a drug at a certain administered volume and over a specified period of time. Insulet has partnered with pharmaceutical and biotechnology companies to tailor the Omnipod System technology platform for the delivery of subcutaneous drugs across other therapeutic areas. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.514B | 24.03 |
| Stryker (SYK) | United States | $129.352B | 30.98 |
| Boston Scientific (BSX) | United States | $113.715B | 36.22 |
| Medtronic (MDT) | Ireland | $103.107B | 15.43 |
| EssilorLuxottica (ESLOY) | France | $101.762B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.392B | 0.00 |
| Haleon (HLN) | United Kingdom | $39.132B | 28.57 |
| ResMed (RMD) | United States | $27.007B | 25.36 |
| Terumo (TRUMY) | Japan | $24.269B | 34.27 |
| Koninklijke Philips (PHG) | Netherlands | $23.059B | 18.30 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.264B | 14.22 |
| Baxter (BAX) | United States | $17.305B | 12.30 |
| Demant (WILYY) | Denmark | $10.984B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.877B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.994B | 26.14 |
| BellRing Brands (BRBR) | United States | $7.556B | 35.54 |
| Lantheus Holdings (LNTH) | United States | $5.677B | 14.15 |
| GN Store Nord (GNNDY) | Denmark | $4.364B | 24.51 |
| Haemonetics (HAE) | United States | $4.251B | 20.96 |
| Perrigo (PRGO) | Ireland | $3.490B | 10.58 |
| Neogen (NEOG) | United States | $3.487B | 33.54 |
| Prestige Consumer Healthcare (PBH) | United States | $3.449B | 16.41 |
| TG Therapeutics (TGTX) | United States | $2.966B | 83.43 |
| ICU Medical (ICUI) | United States | $2.799B | 24.70 |
| Envista Holdings (NVST) | United States | $2.750B | 11.35 |
| Green Thumb Industries (GTBIF) | United States | $2.568B | 50.27 |
| Agios Pharmaceuticals (AGIO) | United States | $2.537B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.203B | 12.23 |
| LeMaitre Vascular (LMAT) | United States | $1.838B | 53.87 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.731B | 0.00 |
| Warby Parker (WRBY) | United States | $1.558B | 0.00 |
| InMode (INMD) | Israel | $1.512B | 8.04 |
| AdaptHealth (AHCO) | United States | $1.289B | 9.58 |
| Verano Holdings (VRNOF) | United States | $1.266B | 0.00 |
| Owens & Minor (OMI) | United States | $1.179B | 10.27 |
| AtriCure (ATRC) | United States | $1.013B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.006B | 32.00 |
| BioLife Solutions (BLFS) | United States | $0.984B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.771B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.710B | 15.12 |
| PetIQ (PETQ) | United States | $0.656B | 21.21 |
| Evolus (EOLS) | United States | $0.654B | 0.00 |
| Surmodics (SRDX) | United States | $0.598B | 37.46 |
| VAREX IMAGING (VREX) | United States | $0.590B | 13.88 |
| Valneva SE (VALN) | France | $0.520B | 0.00 |
| ZimVie (ZIMV) | United States | $0.495B | 42.21 |
| Canopy Growth (CGC) | Canada | $0.494B | 0.00 |
| Quanterix (QTRX) | United States | $0.485B | 0.00 |
| Biote (BTMD) | United States | $0.449B | 10.33 |
| Jin Medical (ZJYL) | China | $0.432B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.417B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.312B | 10.05 |
| Cerus (CERS) | United States | $0.311B | 0.00 |
| Zynex (ZYXI) | United States | $0.274B | 37.52 |
| MacroGenics (MGNX) | United States | $0.269B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.257B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.247B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.245B | 24.31 |
| Sanara MedTech (SMTI) | United States | $0.243B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.237B | 14.90 |
| Omeros (OMER) | United States | $0.225B | 0.00 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.155B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.153B | 21.70 |
| TriSalus Life Sciences (TLSI) | United States | $0.151B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.148B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.140B | 67.00 |
| Quipt Home Medical (QIPT) | United States | $0.130B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.126B | 0.00 |
| Veru (VERU) | United States | $0.116B | 0.00 |
| Brainsway (BWAY) | Israel | $0.104B | 0.00 |
| InterCure (INCR) | Israel | $0.099B | 16.77 |
| Fonar (FONR) | United States | $0.099B | 10.00 |
| Cellectar Biosciences (CLRB) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.090B | 0.00 |
| Chimerix (CMRX) | United States | $0.083B | 0.00 |
| MariMed (MRMD) | United States | $0.072B | 0.00 |
| Bright Green (BGXX) | United States | $0.061B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
| Safety Shot (SHOT) | United States | $0.054B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.050B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.25 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.035B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |